IMVT icon

Immunovant

186 hedge funds and large institutions have $2.04B invested in Immunovant in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

10% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 61

9% less capital invested

Capital invested by funds: $2.24B → $2.04B (-$204M)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
186
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.9M
Puts
$18.2M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
126
$353K
127
$325K
128
$314K
129
$312K
130
$297K
131
$270K
132
$270K
133
$268K
134
$258K
135
$250K
136
$221K
137
$204K
138
$200K
139
$194K
140
$166K
141
$150K
142
$120K
143
$114K
144
$99.3K
145
$85K
146
$77K
147
$76.3K
148
$64.7K
149
$63.8K
150
$61.3K